EMS-Chemie stock: UBS cuts rating to Neutral on valuation
Published on 11/04/2026 at 03:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSUBS reassesses EMS-Chemie valuation
- UBS sees limited room for further multiple expansion after the stock's strong advance.
- The bank still expects a strong fourth quarter and EMS-Chemie to meet its outlook.
- Automotive demand remains a key risk, while Asia is expected to support future growth.
UBS cut its rating on EMS-Chemie from Buy to Neutral on October 28, 2026, citing a valuation that already reflects the company's earnings recovery and new growth areas. Investing.com reported that analyst Patrick Rafaisz raised the price target to CHF 870 from CHF 860 while lowering the recommendation.
Valuation limits the upside
UBS said the stock's roughly 55% advance had brought the earnings recovery and new verticals, including humanoid robotics, into the valuation. The bank estimates earnings per share growth of 6% to 7% a year and sees limited scope for further margin expansion from current record levels.
UBS also described the risk and reward as balanced. It expects 2026 sales of CHF 2.014 billion and EBIT of CHF 609 million, above the cited consensus estimates, while forecasting organic growth of 6.6% in 2027.
Fourth quarter remains in focus
The bank expects fourth-quarter organic growth above 7%, supported by renewed pricing increases of about 4% as input-cost inflation returns. Its outlook assumes global automotive production will recover modestly next year, although Western Europe remains a drag and Asia provides the main growth contribution.
EMS-Chemie shares fell 1.8% in Swiss trading by 11:48 GMT on October 28, according to the Investing.com report. That move followed the rating change in the market account, while the UBS assessment still pointed to a strong fourth quarter.
Specialty chemicals worldwide
EMS-Chemie is a Swiss specialty chemicals maker active worldwide in High Performance Polymers and Specialty Chemicals. According to the company's investor information, the group focuses on high-margin specialties and innovation across these business areas. Its broad industrial exposure includes automotive-related demand, while its specialty focus differentiates the business from more diversified chemical producers.
EMS-Chemie company facts
- Company: EMS-CHEMIE HOLDING AG
- ISIN: CH0016440353
- Business: High Performance Polymers and Specialty Chemicals
- Analyst action: UBS downgraded the stock to Neutral on October 28, 2026
- UBS price target: CHF 870
Swiss equities remain the relevant market setting for EMS-Chemie, with investors weighing valuation and industrial demand across the SMI.
More news and analyses on EMS-Chemie stock.
